Reading Lena Dunham's memoir "Famesick" reminds columnist Mike Naple that a chronic illness is not something that's just ...

The FDA has granted orphan drug designation to IKT-001, an experimental formulation of imatinib being developed to treat PAH.

Researchers have identified shared molecular connections between COVID-19 and PAH that may explain common disease features, a ...

People with PAH have less diversity among the viruses that infect bacteria in the digestive tract, according to a study.

A large clinical trial testing a once-daily inhaled treatment for PAH is now recruiting, after data showed long-term benefits ...

[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a rare but severe disease characterized by high blood pressure in the lungs. The disease affects the pulmonary arteries, which are ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Pulmonary hypertension (PH) is a rare but severe condition characterized by high blood pressure that affects pulmonary arteries – the vessels responsible for transporting blood from the heart to the ...

Respiratory rehabilitation is safe and can help improve exercise capacity in people with chronic obstructive pulmonary disease (COPD) with or without pulmonary hypertension (PH), a study reported. A ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google I live with pulmonary hypertension (PH), and I frequently ignore ...

Testing a pregnant woman’s levels of a protein linked to changes in the heart’s size and shape may help identify expectant mothers with pulmonary arterial hypertension (PAH) who are at high risk of ...

Corvista Health says a new billing code for use in the U.S., to take effect next year, will allow its noninvasive, point-of-care CorVista-PH test — used by clinicians to diagnose pulmonary ...